| Breakdown | TTM | Dec 2024 | Dec 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 5.11B | 7.39B | 6.43B | 5.76B | 3.59B | 3.01B |
| Gross Profit | 717.70M | 1.08B | 906.54M | 624.66M | 583.36M | 566.59M |
| EBITDA | 499.78M | 710.55M | 647.21M | 325.99M | 345.10M | 389.49M |
| Net Income | 275.67M | 450.87M | 369.52M | 215.14M | 168.22M | 226.36M |
Balance Sheet | ||||||
| Total Assets | 5.82B | 5.03B | 6.16B | 6.11B | 3.18B | 2.60B |
| Cash, Cash Equivalents and Short-Term Investments | 387.26M | 425.85M | 378.35M | 1.26B | 247.21M | 174.18M |
| Total Debt | 3.45B | 1.45B | 3.63B | 3.38B | 1.12B | 1.06B |
| Total Liabilities | 4.59B | 3.25B | 4.79B | 4.96B | 2.12B | 1.73B |
| Stockholders Equity | 1.21B | 1.77B | 1.36B | 1.13B | 1.05B | 852.47M |
Cash Flow | ||||||
| Free Cash Flow | -1.69B | 868.29M | 900.88M | -1.70B | 113.77M | 55.89M |
| Operating Cash Flow | -1.47B | 1.05B | 981.37M | -1.49B | 173.12M | 102.64M |
| Investing Cash Flow | -1.76B | 673.43M | -41.55M | -2.31B | -110.96M | -78.91M |
| Financing Cash Flow | 3.07B | -1.65B | -901.37M | 3.83B | -45.12M | -286.15M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | HK$2.45B | 5.82 | 22.34% | 5.75% | 18.32% | 14.06% | |
74 Outperform | HK$1.43B | 8.32 | 8.98% | 6.40% | 13.14% | -28.26% | |
72 Outperform | HK$27.76B | 14.82 | 17.75% | 2.24% | 20.33% | 27.05% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
59 Neutral | HK$31.38B | 42.45 | 34.12% | 0.17% | ― | ― | |
40 Underperform | HK$727.43M | 22.18 | -4.59% | ― | >-0.01% | 98.32% |